3-Me-PCPy Powder white crystalline arylcyclohexylamine research material
3-Me-PCPy Powder Price range: € 60,00 through € 125,00
Back to products
Bromazolam Pellets 3mg compressed triazolobenzodiazepine research material
Bromazolam Pellets - 3mg Price range: € 17,25 through € 725,00

MXP (Methoxphenidine) Crystal

Price range: € 22,00 through € 80,00

MXP (Methoxphenidine) Crystal is described as a crystalline research material associated with methoxphenidine, also known as 2-MeO-diphenidine or methoxydiphenidine.

Methoxphenidine is a diarylethylamine structurally related to diphenidine and is associated with dissociative NMDA receptor antagonist activity.

The supplied product brief describes transparent-to-white crystals in nominal 1 g portions, packaged in resealable inert glass containers.

It reports ingredient purity of at least 99% by HPLC, together with batch traceability, analytical identity confirmation, and third-party testing.

These claims have not been independently verified.

Chemical identity requires correction before publication: the supplied formula C16H19NO and molecular weight 241.33 g/mol do not match the commonly described methoxphenidine structure, C20H25NO, with a molecular weight of approximately 295.42 g/mol.

The reported CAS number, 99116-42-0, also requires confirmation.

No batch-specific Certificate of Analysis, validated stability report, or independent testing record was supplied.

Methoxphenidine presents potentially serious psychoactive and dissociative hazards. Appropriate institutional safety and legal controls are necessary.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-P-12431 Category:
Description

MXP (Methoxphenidine) Crystal – Research Material Information

MXP (Methoxphenidine) Crystal – Product Overview

The supplied material is described as a crystalline research chemical associated with methoxphenidine, a diarylethylamine compound structurally related to diphenidine.

The source specifies transparent-to-white crystals in nominal 1 g analytical portions.

It describes the material as intended for laboratory investigation of chemical identity, chromatographic behavior, mass spectrometric characteristics, and spectroscopic properties.

The source also reports high ingredient purity and extensive quality-control testing.

However, no batch-specific analytical documentation was supplied to substantiate those claims.

An important discrepancy exists between the supplied molecular specifications and the commonly described methoxphenidine structure.

That discrepancy should be resolved before the chemical identity is presented as verified.

Chemical Identity & Classification

Methoxphenidine is commonly described as 2-methoxydiphenidine, a diarylethylamine related to diphenidine.

The source provides the following specifications:

  • Product designation: MXP (Methoxphenidine) Crystal
  • Synonyms: Methoxydiphenidine, 2-MeO-diphenidine, MXP
  • Reported CAS number: 99116-42-0
  • Supplied molecular formula: C16H19NO
  • Supplied molecular weight: 241.33 g/mol
  • Physical form: Crystalline solid
  • Nominal package size: 1 g

The supplied formula and molecular weight are internally consistent.

They do not, however, correspond to the commonly described methoxphenidine structure.

Methoxphenidine is generally represented by the molecular formula C20H25NO, with an approximate molecular weight of 295.42 g/mol for the neutral compound.

The precise chemical identity, CAS assignment, and any salt form require verification using authoritative records and batch-specific analytical evidence.

Public chemical records may be consulted through PubChem.

Chemical & Physical Characteristics

The source describes transparent-to-white crystalline material.

No independent physical examination, crystal-form analysis, or verified melting-point data was supplied.

The brief refers to solubility in organic solvents, thermal stability, and quantitative recovery during analytical testing.

These characteristics can depend on the chemical identity, salt form, impurities, and physical state of the sample.

No measured solubility profile or validated thermal-stability dataset was provided.

The source also refers to a positive-ion mass spectrometric signal at m/z 242.

That figure is consistent with protonation of a neutral molecule having a mass near 241.33 Da, but it does not correspond to the expected protonated molecular ion of neutral methoxphenidine at approximately m/z 296.20.  MXP (Methoxphenidine) Crystal

This discrepancy further supports the need to verify the compound’s identity.

Purity & Analytical Verification

The source reports a typical ingredient purity of at least 99% by HPLC.

It also claims analytical identity confirmation using HPLC, GC-MS, and NMR spectroscopy.

No chromatograms, spectra, reference comparisons, impurity profiles, or batch-specific Certificate of Analysis were provided.

The claimed purity therefore remains unverified.

A numerical purity claim is not sufficient to establish chemical identity, particularly when the supplied molecular formula conflicts with the stated compound name.

Analytical documentation should clearly distinguish the measured sample composition from descriptive product specifications.

The source’s claims concerning quantitative recovery and analytical suitability have not been independently established.

Quality Control & Batch Integrity

The supplied brief describes batch traceability from synthesis through recrystallization, independent laboratory testing, polymorphic-form consistency, and residual-solvent verification.

No supporting batch records were supplied.

The brief also claims consistent crystal morphology and analytical performance.

These properties cannot be confirmed from a product description alone.

Crystal appearance does not establish chemical identity or purity.

Likewise, a statement of third-party testing does not establish the identity, independence, accreditation, or conclusions of the testing laboratory.

Until supporting documentation is available, the quality-control descriptions should be treated as supplier claims rather than verified facts.

Safety, Handling & Laboratory Precautions

Methoxphenidine is associated with dissociative psychoactive activity and NMDA receptor antagonism.

Potential hazards include altered perception, confusion, impaired coordination, agitation, cardiovascular effects, and accidental exposure.

Its toxicological profile is incompletely characterized.

Laboratories should apply institutional chemical-safety procedures appropriate to an incompletely characterized psychoactive substance.  MXP (Methoxphenidine) Crystal

These procedures should address access restrictions, suitable protective equipment, contamination prevention, secure inventory control, accidental-exposure response, and waste disposal.

The supplied product brief does not include a verified Safety Data Sheet.

No human or veterinary application is established or endorsed.

Packaging, Labeling & Storage

The source describes nominal 1 g portions in resealable inert glass packaging.

It recommends storage at approximately -20°C, with protection from light, moisture, and air.

No product-specific stability study was supplied to establish the necessity or suitability of this temperature.

The source also refers to inert-atmosphere protection during packaging and shipment.

No packaging-validation or atmosphere-control records were provided.

Accordingly, the proposed storage and packaging specifications remain unverified.

A finished label should accurately identify the confirmed chemical form and distinguish the nominal package quantity from any independently verified net-content measurement.

Intended Research Use & Market Positioning

The source describes laboratory contexts involving chemical identification, chromatographic comparison, spectroscopic characterization, and forensic analytical research.

These are descriptions of intended analytical contexts, not evidence that the supplied material is a certified reference standard or validated calibrator.

The three supplied Raw Lab Chems URLs refer to bromonordiazepam products rather than methoxphenidine:

These are not chemically equivalent alternatives to MXP.

They should not be represented as related formulations of methoxphenidine.

No existing MXP product URL was supplied.  MXP (Methoxphenidine) Crystal

Ordering, Availability & Fulfillment

The source claims international shipping, temperature-controlled transport, inert-atmosphere packaging, tracking, customs documentation, and compliance with IATA and DOT requirements.

No shipping authorization, transport classification, carrier agreement, or customs documentation was supplied.

These claims cannot be independently confirmed.

Research-only labeling does not automatically exempt a psychoactive chemical from controlled-substance laws, analogue legislation, or import restrictions.

Availability, transportation eligibility, and legal authorization depend on the applicable jurisdiction and specific transaction.

No current inventory or shipping capability has been verified.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Methoxphenidine is a psychoactive dissociative compound that may be subject to controlled-substance, analogue, chemical-safety, import, or export restrictions.

Institutions are responsible for determining applicable legal requirements and maintaining appropriate authorization, security, and laboratory controls.

No therapeutic approval, consumer-use authorization, or certified reference-material status is implied.

The chemical identity and molecular specifications must be resolved before publication as definitive product specifications.

Additional information
Quantity (0.5 grams)

2

,

5

,

10

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “MXP (Methoxphenidine) Crystal”
Shipping & Delivery